Trial intelligence / Profile preview

MoMO PIP: Maternal Vitamin D Supplementation

NCT04629534Phase 4Terminated

Sponsor
Medical University of South Carolina
Start
May 2021
Primary completion
Dec 2021
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of vitamin d in Vitamin D deficiency (VDD) (2 arms), sponsored by Medical University of South Carolina. Primary endpoints: Number of Infants With Sufficient 25(OH)D Stores at 3 months, Number of Mothers With Sufficient 25(OH)D Stores at 3 months and 3 more. Started May 2021; status: terminated.

02

Drugs

vitamin d
03

Conditions

Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on NCT04629534.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04629534.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call